1. Hwang, Soo Seok, Lim, Jaechul, Yu, Zhibin, Li, Hua-Bing, Flavell, Richard A. . mRNA destabilization by BTG1 and BTG2 maintains T cell quiescence. In Science (New York, N.Y.), 367, 1255-1260. doi:10.1126/science.aax0194. https://pubmed.ncbi.nlm.nih.gov/32165587/
2. Yuniati, Laurensia, Scheijen, Blanca, van der Meer, Laurens T, van Leeuwen, Frank N. 2018. Tumor suppressors BTG1 and BTG2: Beyond growth control. In Journal of cellular physiology, 234, 5379-5389. doi:10.1002/jcp.27407. https://pubmed.ncbi.nlm.nih.gov/30350856/
3. Mlynarczyk, Coraline, Teater, Matt, Pae, Juhee, Victora, Gabriel D, Melnick, Ari. 2023. BTG1 mutation yields supercompetitive B cells primed for malignant transformation. In Science (New York, N.Y.), 379, eabj7412. doi:10.1126/science.abj7412. https://pubmed.ncbi.nlm.nih.gov/36656933/
4. Velayutham, Nivedhitha, Calderon, Maria Uscategui, Alfieri, Christina M, Scheijen, Blanca, Yutzey, Katherine E. 2023. Btg1 and Btg2 regulate neonatal cardiomyocyte cell cycle arrest. In Journal of molecular and cellular cardiology, 179, 30-41. doi:10.1016/j.yjmcc.2023.03.016. https://pubmed.ncbi.nlm.nih.gov/37062247/
5. Delage, Lorric, Lambert, Mireille, Bardel, Émilie, Rouault, Jean-Pierre, Sujobert, Pierre. . BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1. In Blood, 141, 1209-1220. doi:10.1182/blood.2022016943. https://pubmed.ncbi.nlm.nih.gov/36375119/
6. Li, Yibing, Huo, Jianing, He, Junjian, Zhang, Yunzheng, Ma, Xiaoxin. 2020. BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma. In Cancer cell international, 20, 490. doi:10.1186/s12935-020-01591-3. https://pubmed.ncbi.nlm.nih.gov/33041670/
7. Zheng, Hua-Chuan, Xue, Hang, Zhang, Cong-Yu, Shi, Kai-Hang, Zhang, Rui. 2022. The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis. In Frontiers in genetics, 13, 1006636. doi:10.3389/fgene.2022.1006636. https://pubmed.ncbi.nlm.nih.gov/36339000/
智鼠故事 
